The pathophysiological background of the haemodynamic changes in chronic po
rtal hypertension is still only partly understood. An important factor is t
he so-called "forward theory", explaining the systemic and especially splan
chnic vasodilation observed. Nitric oxide (NO) is an important mediator of
this vasodilatory state. Structural as well as vascular changes seem to be
causative factors in this vasodilation. These alterations can be studied by
a newly-developed in vivo angiogenesis assay. Rats with portal hypertensio
n show increased angiogenesis and NO appears to be a mediator of this findi
ng. The interaction(s) of NO with other angiogenic molecules is now being e
xplored. A better understanding of these structural vascular changes map he
lp to develop new therapeutic strategies in the future.